Giorgio Racagni

Q: What Schools Are Affiliated With Giorgio Racagni

Giorgio Racagni is affiliated with the following schools: University of Milan, University of Pavia

Giorgio Racagni's AcademicInfluence.com Rankings

Giorgio Racagni

Biology

#7827

World Rank

#10803

Historical Rank

Neuroscience

#1045

World Rank

#1087

Historical Rank

biology Degrees

Download Badge

Biology

Giorgio Racagni's Degrees

PhD Neuroscience University of Milan
Masters Biology University of Milan

Similar Degrees You Can Earn

Best Online Master's in Biology

Why Is Giorgio Racagni Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Giorgio Racagni's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes (1994) (474)
Early maternal deprivation reduces the expression of BDNF and NMDA receptor subunits in rat hippocampus (2002) (437)
Treatment resistant depression: methodological overview and operational criteria (1999) (395)
Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity (2014) (377)
Peroxynitrite Inhibits Glutamate Transporter Subtypes (*) (1996) (376)
Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions (2004) (328)
Guidelines for depot antipsychotic treatment in schizophrenia (1998) (312)
Signaling Pathways Regulating Gene Expression, Neuroplasticity, and Neurotrophic Mechanisms in the Action of Antidepressants: A Critical Overview (2006) (306)
Neuronal plasticity: A link between stress and mood disorders (2009) (288)
Acute Stress Increases Depolarization-Evoked Glutamate Release in the Rat Prefrontal/Frontal Cortex: The Dampening Action of Antidepressants (2010) (263)
Posttraumatic Stress Disorder: Diagnosis and Epidemiology, Comorbidity and Social Consequences, Biology and Treatment (2001) (255)
Projections of substance P containing neurons from neostriatum to substantia nigra (1977) (254)
Chronic Antidepressants Reduce Depolarization-Evoked Glutamate Release and Protein Interactions Favoring Formation of SNARE Complex in Hippocampus (2005) (228)
Stress during development: Impact on neuroplasticity and relevance to psychopathology (2007) (214)
Current pharmacological treatments for COVID‐19: What's next? (2020) (211)
Neuronal and Glial Glutamate Transporters Possess an SH‐based Redox Regulatory Mechanism (1997) (193)
The role of noradrenaline and selective noradrenaline reuptake inhibition in depression (2002) (189)
Selective Phosphorylation of Nuclear CREB by Fluoxetine is Linked to Activation of CaM Kinase IV and MAP Kinase Cascades (2004) (186)
New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine (1995) (185)
Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms. (1994) (178)
International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets (2018) (173)
Choline acetyltransferase activity and mass fragmentographic measurement of acetylcholine in specific nuclei and tracts of rat brain (1975) (160)
Glucocorticoid Receptor and FKBP5 Expression Is Altered Following Exposure to Chronic Stress: Modulation by Antidepressant Treatment (2013) (160)
Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. (2000) (153)
Modulation of synaptic plasticity by stress and antidepressants. (2002) (147)
Mass fragmentographic measurement of norepinephrine dopamine, serotonin and acetylcholine in seven discrete nuclei of the rat tel-diencephalon. (1974) (146)
In vivo inhibition of striatal acetylcholine turnover by L-DOPA, apomorphine and (+)-amphetamine (1975) (145)
Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics (2000) (144)
Cellular and molecular mechanisms in the long-term action of antidepressants. (2008) (141)
GABAergic control of anterior pituitary hormone secretion. (1982) (136)
Corticostriatal brain‐derived neurotrophic factor dysregulation in adult rats following prenatal stress (2004) (130)
Chronic Duloxetine Treatment Induces Specific Changes in the Expression of BDNF Transcripts and in the Subcellular Localization of the Neurotrophin Protein (2007) (126)
Arachidonic Acid Inhibits a Purified and Reconstituted Glutamate Transporter Directly from the Water Phase and Not via the Phospholipid Membrane (*) (1995) (125)
Mode of action of agomelatine: Synergy between melatonergic and 5-HT2C receptors (2011) (125)
Typical and atypical antidepressants. Molecular mechanisms. (1982) (118)
The Competitive Transport Inhibitor L‐trans‐pyrrolidine‐2,4‐dicarboxylate Triggers Excitotoxicity in Rat Cortical Neuron‐Astrocyte Co‐cultures via Glutamate Release rather than Uptake Inhibition (1996) (117)
Second Messenger‐Regulated Protein Kinases in the Brain (2000) (117)
Stress, glucocorticoids and glutamate release: Effects of antidepressant drugs (2011) (116)
Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions. (2006) (112)
Modulation of fibroblast growth factor-2 by stress and corticosteroids: from developmental events to adult brain plasticity (2001) (112)
Chronic fluoxetine administration inhibits extracellular signal‐regulated kinase 1/2 phosphorylation in rat brain (2005) (111)
Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain (2004) (111)
Noradrenaline in mood and anxiety disorders: basic and clinical studies (2003) (109)
Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans (2010) (108)
Involvement of brain cholinergic mechanisms in the action of chlorpromazine (1974) (108)
Repeated exposure to cocaine differently modulates BDNF mRNA and protein levels in rat striatum and prefrontal cortex (2007) (108)
Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy. (1998) (106)
Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex (2014) (105)
Measurement of acetylcholine turnover rate in discrete areas of rat brain. (1974) (100)
Regulation of Editing and Expression of Glutamate α-Amino-Propionic-Acid (AMPA)/Kainate Receptors by Antidepressant Drugs (2006) (98)
cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment. (1989) (98)
Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine (2012) (95)
Dual y-Aminobutyric Acid Control of Prolactin Secretion in the Rat* (1979) (94)
Ultrasonic vocalization in response to unavoidable aversive stimuli in rats: effects of benzodiazepines. (1988) (93)
Stress-Induced Changes of Hippocampal NMDA Receptors: Modulation by Duloxetine Treatment (2012) (89)
Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro. (1995) (89)
Differential sensitivity to morphine-induced analgesia and motor activity in two inbred strains of mice: behavioral and biochemical correlations. (1979) (81)
BDNF gene expression is reduced in the frontal cortex of dopamine transporter knockout mice (2003) (81)
Effect of antipsychotic drugs on brain‐derived neurotrophic factor expression under reduced N‐methyl‐D‐aspartate receptor activity (2003) (81)
Regulation of NMDA receptor subunit mRNA expression in the rat brain during postnatal development. (1994) (80)
Reactive Oxygen Species Inhibit High‐Affinity Glutamate Uptake: Molecular Mechanism and Neuropathological Implications (1994) (80)
In vivo actions of clozapine and haloperidol on the turnover rate of acetylcholine in rat striatum. (1976) (79)
Developmental and stress-related changes of neurotrophic factor gene expression in an animal model of schizophrenia (2001) (78)
GABA of CNS origin in the rat anterior pituitary inhibits prolactin secretion (1979) (78)
Reduced neuroplasticity in aged rats: a role for the neurotrophin brain-derived neurotrophic factor (2013) (78)
cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity. (1991) (78)
Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome. (1996) (77)
The pharmacological properties of antidepressants (2010) (76)
Pharmacokinetics interactions of monoclonal antibodies. (2016) (76)
Acute Stress Responsiveness of the Neurotrophin BDNF in the Rat Hippocampus is Modulated by Chronic Treatment with the Antidepressant Duloxetine (2009) (75)
Pharmacokinetic drug interactions of the non‐vitamin K antagonist oral anticoagulants (NOACs) (2018) (74)
Direct and indirect costs of schizophrenia in community psychiatric services in Italy: The GISIES study (2000) (73)
An analysis at synaptic level of the morphine action in striatum and N. accumbens: dopamine and acetylcholine interactions. (1975) (73)
Regulation of NMDA receptor subunit messenger RNA levels in the rat brain following acute and chronic exposure to antipsychotic drugs. (1997) (73)
PGF2 alpha, thromboxane B2 and HETE levels in gerbil brain cortex after ligation of common carotid arteries and decapitation. (1979) (72)
Inhibition of nitric oxide synthase dramatically potentiates seizures induced by kainic acid and pilocarpine in rats (1995) (72)
Effect of reboxetine, a new antidepressant drug, on the central noradrenergic system: Behavioural and biochemical studies (1989) (72)
Temporal sequence of changes in central noradrenergic system of rat after prolonged antidepressant treatment: Receptor desensitization and neurotransmitter interactions (1983) (71)
Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus (2007) (71)
Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression. (2009) (71)
Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801 (2004) (70)
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis (2011) (70)
Action of opiates, antipsychotics, amphetamine and apomorphine on dopamine receptors in rat striatum: in vivo changes of 3′,5′-cyclic amp content and acetylcholine turnover rate (1975) (70)
Antipsychotic drug actions on gene modulation and signaling mechanisms. (2009) (70)
cAMP cascade leads to Ras activation in cortical neurons. (2000) (69)
Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain: Restorative effect of pharmacological intervention. (2016) (68)
Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine (2011) (68)
Depression and Sleep Disorders: Clinical Relevance, Economic Burden and Pharmacological Treatment (2000) (66)
Prenatal stress alters glutamatergic system responsiveness in adult rat prefrontal cortex (2009) (65)
Abnormalities of cAMP signaling in affective disorders: implication for pathophysiology and treatment. (2000) (65)
Effects of acute and chronic morphine on regional rat brain acetylcholine turnover rate. (1974) (65)
Prophylactic Use of Anticholinergics in Patients on Long-Term Neuroleptic Treatment (1990) (65)
Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder. (1999) (65)
Synergistic mechanisms in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration (2010) (64)
Short- and long-term induction of basic fibroblast growth factor gene expression in rat central nervous system following kainate injection (1994) (63)
Modulation of BDNF expression by repeated treatment with the novel antipsychotic lurasidone under basal condition and in response to acute stress. (2012) (63)
Dynamic Regulation of Glutamatergic Postsynaptic Activity in Rat Prefrontal Cortex by Repeated Administration of Antipsychotic Drugs (2008) (63)
Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants (2009) (62)
Prenatal stress elicits regionally selective changes in basal FGF-2 gene expression in adulthood and alters the adult response to acute or chronic stress (2005) (62)
Typical and atypical antidepressants. Clinical practice. (1982) (61)
Acute Stress Responsiveness of the Neurotrophin BDNF in the Rat Hippocampus is Modulated by Chronic Treatment with the Antidepressant Duloxetine (2009) (60)
Presynaptic Ca2+/calmodulin-dependent protein kinase II: autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake. (1995) (60)
Current pharmacological treatments for COVID-19: what’s next? (2020) (60)
Long-Term Duloxetine Treatment Normalizes Altered Brain-Derived Neurotrophic Factor Expression in Serotonin Transporter Knockout Rats through the Modulation of Specific Neurotrophin Isoforms (2010) (59)
Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways (2010) (59)
A role for the arachidonic acid cascade in fast synaptic modulation: ion channels and transmitter uptake systems as target proteins. (1992) (59)
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. (2010) (59)
Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels (2011) (58)
NSAIDs in patients with viral infections, including Covid-19: Victims or perpetrators? (2020) (57)
Ultrasonic vocalization in rat pups: effects of early postnatal exposure to haloperidol. (1986) (57)
Opposite Regulation of Basic Fibroblast Growth Factor and Nerve Growth Factor Gene Expression in Rat Cortical Astrocytes Following Dexamethasone Treatment (1995) (56)
Depression-prone mice with reduced glucocorticoid receptor expression display an altered stress-dependent regulation of brain-derived neurotrophic factor and activity-regulated cytoskeleton-associated protein (2010) (56)
Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats (2001) (55)
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety (2021) (55)
Effect of progesterone, testosterone and their 5α-reduced metabolites on GFAP gene expression in type 1 astrocytes (1996) (54)
Constant rate infusion of deuterated phosphorylcholine to measure the effects of morphine on acetylcholine turnover rate in specific nuclei of rat brain (1977) (54)
Abnormalities of cAMP-dependent endogenous phosphorylation in platelets from patients with bipolar disorder. (1995) (54)
Perspective: Improving Nutritional Guidelines for Sustainable Health Policies: Current Status and Perspectives (2017) (54)
New biochemical hypotheses on the mechanism of action of antidepressant drugs: cAMP-dependent phosphorylation system. (1992) (53)
Synergistic mechanisms involved in the antidepressant effects of agomelatine (2012) (53)
Early-life stress and antidepressant treatment involve synaptic signaling and Erk kinases in a gene-environment model of depression. (2010) (52)
The interaction between the internal clock and antidepressant efficacy (2007) (52)
Emerging role of the FGF system in psychiatric disorders. (2005) (52)
GABA synthesis in Schwann cells is induced by the neuroactive steroid allopregnanolone (2010) (52)
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism (2005) (52)
Chronic Antidepressants Induce Redistribution and Differential Activation of αCaM Kinase II between Presynaptic Compartments (2007) (51)
Prolonged abstinence from developmental cocaine exposure dysregulates BDNF and its signaling network in the medial prefrontal cortex of adult rats. (2014) (51)
Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: comparison with fibroblast growth factor-1 and ciliary neurotrophic factor. (1996) (50)
Regulation of Ionotropic Glutamate Receptors in the Rat Brain in Response to the Atypical Antipsychotic Seroquel (Quetiapine Fumarate) (1999) (50)
Correlation between analgesia and the decrease of acetylcholine turnover rate in cortex and hippocampus elicited by morphine, meperidine, viminol R2 and azidomorphine. (1976) (48)
Protein kinase A and Rap1 levels in platelets of untreated patients with major depression (2001) (48)
Consensus conference on the methodology of clinical trials of antidepressants, Zurich, march 1988: report of the consensus committee (1989) (48)
Repeated stress prevents cocaine-induced activation of BDNF signaling in rat prefrontal cortex (2009) (47)
Functional interaction between rat substantia nigra and striatum: GABA and dopamine interrelation (1977) (46)
In vivo studies on central noradrenergic synaptic mechanisms after acute and chronic antidepressant drug treatment: biochemical and behavioral comparison. (1982) (46)
Corticostriatal Up-Regulation of Activity-Regulated Cytoskeletal-Associated Protein Expression after Repeated Exposure to Cocaine (2006) (46)
Region-specific effects on BDNF expression after contingent or non-contingent cocaine i.v. self-administration in rats. (2013) (45)
Early induction of CREB activation and CREB-regulating signalling by antidepressants. (2009) (44)
Genotype-dependent sensitivity to morphine: dopamine involvement in morphine-induced running in the mouse (1976) (44)
Selective modulation of fibroblast growth factor-2 expression in the rat brain by the atypical antipsychotic clozapine (1999) (43)
Critical issues in the treatment of affective disorders (1995) (43)
Synaptoproteomics of learned helpless rats involve energy metabolism and cellular remodeling pathways in depressive-like behavior and antidepressant response (2011) (42)
Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas. (1999) (42)
Consensus on the Use of Substituted Benzamides in Psychiatric Patients (2004) (42)
Mechanisms subserving the stimulatory and inhibitory components of gamma-aminobutyric acid-ergic control of prolactin secretion in the rat. (1981) (41)
Modulation of opioid system in C57 mice after repeated treatment with morphine and naloxone: biochemical and behavioral correlates. (1984) (41)
The measurement of acetylcholine turnover rate in brain structures (1976) (40)
Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation (2004) (40)
Rationale for the development of noradrenaline reuptake inhibitors (1998) (40)
Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid (2013) (39)
Transynaptic mechanisms in the action of antidepressant drugs (1984) (39)
Age-related changes in rat serotonergic and adrenergic systems and in receptor responsiveness to subchronic desipramine treatment. (1988) (39)
Antidepressant Treatments Change 5-HT2C Receptor mRNA Expression in Rat Prefrontal/Frontal Cortex and Hippocampus (2011) (39)
Dynamic regulation of fibroblast growth factor 2 (FGF‐2) gene expression in the rat brain following single and repeated cocaine administration (2006) (39)
Lack of Serotonin Transporter Alters BDNF Expression in the Rat Brain During Early Postnatal Development (2013) (39)
Single session of cocaine intravenous self-administration shapes goal-oriented behaviours and up-regulates Arc mRNA levels in rat medial prefrontal cortex. (2009) (39)
Physiology to functionality: the brain and neurotransmitter activity. (1999) (38)
Selective regulation of presynaptic Calcium/Calmodulin-Dependent protein kinase II by psychotropic drugs (2003) (38)
Correction: Acute Stress Increases Depolarization-Evoked Glutamate Release in the Rat Prefrontal/Frontal Cortex: The Dampening Action of Antidepressants (2010) (37)
beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease. (1996) (37)
GABA and endocrine function (1986) (37)
Behavioural and neurochemical changes in offspring of rats exposed to methyl mercury during gestation. (1984) (37)
Exposure to early life stress regulates Bdnf expression in SERT mutant rats in an anatomically selective fashion (2015) (37)
Long-term blockade of serotonin reuptake affects synaptotagmin phosphorylation in the hippocampus. (1997) (37)
Abnormal Levels of cAMP-dependent Protein Kinase Regulatory Subunits in Platelets from Schizophrenic Patients (2000) (36)
Analgesia and motor activity elicited by morphine and enkephalins in two inbred strains of mice (1978) (36)
Long-Term Exposure to the Atypical Antipsychotic Olanzapine Differently Up-Regulates Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylation in Subcellular Compartments of Rat Prefrontal Cortex (2006) (36)
Effects of Lithium on cAMP-Dependent Protein Kinase in Rat Brain (1998) (35)
Developmental Influence of the Serotonin Transporter on the Expression of Npas4 and GABAergic Markers: Modulation by Antidepressant Treatment (2012) (35)
Pentobarbital and in vivo turnover rate of acetylcholine in mouse brain and in regions of rat brain. (1975) (35)
Recent advances in the treatment of neurodegenerative disorders and cognitive dysfunction (1994) (35)
Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat. (1985) (35)
cAMP-dependent phosphorylation system after short and long-term administration of moclobemide. (1998) (34)
Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats. (2013) (34)
Direct and indirect costs of schizophrenia in community psychiatric services in Italy. The GISIES study. Interdisciplinary Study Group on the Economic Impact of Schizophrenia. (2000) (34)
Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia (2001) (34)
Prolactin-inhibiting activity of gamma-aminobutyric acid-mimetic drugs in the male rat (1978) (33)
Pharmacological characterization of BDNF promoters I, II and IV reveals that serotonin and norepinephrine input is sufficient for transcription activation. (2014) (33)
Age-related variations in relative abundance of alternative spliced D2 receptor mRNAs in brain areas of two rat strains. (1992) (33)
Differential effects of lithium on platelet protein phosphorylation in bipolar patients and healthy subjects (1997) (33)
Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells (2008) (33)
Anxious depression : assessment and treatment (1987) (33)
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes (2013) (32)
Acute spinal cord injury persistently reduces R/G RNA editing of AMPA receptors (2010) (32)
Neurotrophic Factors in Neurodegenerative Disorders (2008) (32)
Stress rapidly dysregulates the glutamatergic synapse in the prefrontal cortex of cocaine‐withdrawn adolescent rats (2015) (32)
Hypoglycemia-activated K+ channels in hippocampal neurons (1992) (31)
Association Study of –1727 A/T, –50 C/T and (CAA)n Repeat GSK-3β Gene Polymorphisms with Schizophrenia (2004) (31)
Altered Rap1 endogenous phosphorylation and levels in platelets from patients with bipolar disorder. (2000) (31)
Age-related changes in 5HT uptake and [3H]imipramine binding sites in rat cerebral cortex. (1985) (31)
Abnormalities in α/β-CaMKII and related mechanisms suggest synaptic dysfunction in hippocampus of LPA1 receptor knockout mice. (2011) (31)
Effects of an extract of Ginkgo biloba on noradrenergic systems of rat cerebral cortex. (1985) (31)
Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review (2020) (31)
Serine/threonine kinases as molecular targets of antidepressants: implications for pharmacological treatment and pathophysiology of affective disorders. (2001) (31)
Therapeutic strategies to fight COVID‐19: Which is the status artis? (2021) (30)
Basal and stress-induced modulation of activity-regulated cytoskeletal associated protein (Arc) in the rat brain following duloxetine treatment (2008) (30)
Allelic Variation in the Human Prodynorphin Gene Promoter and Schizophrenia (2002) (30)
Differences in the action of various drugs on striatal acetylcholine and choline content in rats killed by decapitation or microwave radiation (1976) (30)
Dopaminergic D2 receptor activation modulates FGF‐2 gene expression in rat prefrontal cortex and hippocampus (2003) (30)
Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis (2019) (29)
Single exposure to erythropoietin modulates Nerve Growth Factor expression in the spinal cord following traumatic injury: comparison with methylprednisolone. (2008) (29)
Use of microwave techniques to inactivate brain enzymes rapidly. (1982) (28)
Antipsychotic drugs modulate Arc expression in the rat brain (2009) (28)
Role of central nervous system-derived or circulating gamma-aminobutyric acid on prolactin secretion in the rat. (1981) (28)
3-Methoxytyramine and different neuroleptics: dissociation from HVA and DOPAC. (1978) (28)
Depression and cardiovascular risk—association among Beck Depression Inventory, PCSK9 levels and insulin resistance (2020) (28)
Daily fluctuations in the activity of the tuberoinfundibular GABAergic system and plasma prolactin levels. (1984) (27)
Ultrasonic vocalization in rat pups: Effects of early postnatal exposure to SCH 23390 (a DA1-receptor antagonist) and sulpiride (a DA2-receptor antagonist) (1987) (27)
Repeated aripiprazole treatment regulates Bdnf, Arc and Npas4 expression under basal condition as well as after an acute swim stress in the rat brain. (2014) (27)
Chronic phencyclidine administration reduces the expression and editing of specific glutamate receptors in rat prefrontal cortex (2007) (27)
Biochemical and functional aspects on the control of prolactin release by the hypothalamo-pituitary GABAergic system (1989) (27)
Chronic treatments in neuropsychiatry (1985) (27)
Acute Footshock Stress Induces Time-Dependent Modifications of AMPA/NMDA Protein Expression and AMPA Phosphorylation (2016) (27)
Kappa-opioid receptor changes and neurophysiological alterations during cerebral ischemia in rabbits. (1990) (27)
Repeated electroconvulsive shock (ECS) alters the phosphorylation of glutamate receptor subunits in the rat hippocampus. (2010) (26)
Inhibitory effect of lithium on cAMP dependent phosphorylation system. (1996) (26)
Determination of dopamine in the anterior pituitary as an index of tubero-infundibular dopaminergic function (1980) (26)
EFFECT OF SOME TRICYCLIC AND NONTRICYCLIC ANTIDEPRESSANTS ON [3H]IMIPRAMINE BINDING AND SEROTONIN UPTAKE IN RAT CEREBRAL CORTEX AFTER PROLONGED TREATMENT (1987) (26)
Short-term withdrawal from developmental exposure to cocaine activates the glucocorticoid receptor and alters spine dynamics (2015) (26)
Effect of Different Photoperiod Exposure on [3H]Imipramine Binding and Serotonin Uptake in the Rat Brain (1989) (26)
cAMP signaling pathway in depressed patients with psychotic features (2002) (25)
Ethanolamine-O-sulfate enhances gamma-aminobutyric acid secretion into hypophysial portal blood and lowers serum prolactin concentrations. (1983) (25)
Reduced CREB phosphorylation after chronic lithium treatment is associated with down-regulation of CaM kinase IV in rat hippocampus. (2007) (24)
Ultrasonic vocalization in rat pups as a marker of behavioral development: an investigation of the effects of drugs influencing brain opioid system. (1988) (24)
Developmental Influence of the Serotonin Transporter on the Expression of Npas4 and GABAergic Markers: Modulation by Antidepressant Treatment (2012) (24)
Adrenalectomy reduces FGF-1 and FGF-2 gene expression in specific rat brain regions and differently affects their induction by seizures. (1995) (24)
A new nomenclature for classifying psychotropic drugs. (2017) (23)
Altered cAMP-dependent protein kinase A in platelets of patients with obsessive-compulsive disorder. (2000) (23)
L‐Deprenyl potentiates cAMP‐induced elevation of FGF‐2 mRNA levels in rat cortical astrocytes (1997) (23)
Regulation of prolactin secretion during suckling: involvement of the hypothalamo-pituitary GABAergic system (1984) (23)
Portal-Systemic Encephalopathy in Dogs: Changes in Brain GABA Receptors and Neurochemical Correlates (1984) (23)
Accumulation of cGMP in striatum of rats injected with narcotic analgesics: antagonism by naltrexone (1976) (23)
Protein kinase A activity in platelets from patients with bipolar disorder. (2003) (23)
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)? (2020) (22)
Differential regulation of FGF-2 and FGFR-1 in rat cortical astrocytes by dexamethasone and isoproterenol. (1998) (22)
Reduction of Corticostriatal Glutamatergic Fibers in Basic Fibroblast Growth Factor Deficient Mice is Associated with Hyperactivity and Enhanced Dopaminergic Transmission (2007) (22)
Inhibitory effect of the neuroprotective agent idebenone on arachidonic acid metabolism in astrocytes. (1999) (22)
Acute spinal cord injury reduces brain derived neurotrohic factor expression in rat hippocampus (2009) (22)
The AMPA receptor potentiator Org 26576 modulates stress-induced transcription of BDNF isoforms in rat hippocampus. (2012) (22)
Prolactin in cerebrospinal fluid increases the synthesis and release of hypothalamic gamma-aminobutyric acid. (1985) (21)
Ontogenetic study of [3H]imipramine binding sites and serotonin uptake system: indication of possible interdependence. (1982) (21)
Altered expression and modulation of activity-regulated cytoskeletal associated protein (Arc) in serotonin transporter knockout rats (2009) (21)
The role of dopamine D3 receptors in the mechanism of action of cariprazine (2019) (21)
Chronic cocaine administration modulates the expression of transcription factors involved in midbrain dopaminergic neuron function (2007) (21)
Behavioural changes after acute and chronic administration of typical and atypical antidepressants in rats: Interactions with reserpine (1983) (21)
Non‐insulin anti‐diabetic drugs: An update on pharmacological interactions (2017) (20)
AMPA GluR‐A receptor subunit mediates hippocampal responsiveness in mice exposed to stress (2010) (20)
Centella asiatica L. Phytosome Improves Cognitive Performance by Promoting Bdnf Expression in Rat Prefrontal Cortex (2020) (20)
Stress and cocaine interact to modulate basic fibroblast growth factor (FGF-2) expression in rat brain (2008) (20)
Short-term abstinence from cocaine self-administration, but not passive cocaine infusion, elevates αCaMKII autophosphorylation in the rat nucleus accumbens and medial prefrontal cortex. (2014) (20)
Developmental Exposure to Cocaine Dynamically Dysregulates Cortical Arc/Arg3.1 Modulation in Response to a Challenge (2017) (19)
Prolactin control by the tubero-infundibular gabaergic system: role of anterior pituitary GABA receptors (1984) (19)
Modifications in Brain CaM Kinase II after Long-Term Treatment with Desmethylimipramine (2001) (19)
Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra (1978) (18)
Heterologous sensitization of adenylate cyclase activity by serotonin in the rat cerebral cortex (1993) (18)
Chronic Mild Stress Modulates Activity-Dependent Transcription of BDNF in Rat Hippocampal Slices (2015) (18)
Current understanding of the mechanism of action of classic and newer antidepressant drugs (1994) (18)
From Healthy Aging to Frailty: In Search of the Underlying Mechanisms. (2019) (18)
Acute and chronic changes in K(+)-induced depolarization alter NMDA and nNOS gene expression in cultured cerebellar granule cells. (1996) (17)
Altered inflammatory responsiveness in serotonin transporter mutant rats (2013) (17)
Interaction of beta-casomorphins with multiple opioid receptors: in vitro and in vivo studies in the newborn rat brain. (1986) (17)
Experimental brain tumors by transplacental ENU. Multifactorial study of the latency period. (1980) (17)
Difference in the development of tolerance to morphine and D-ALA2-methionine-enkephalin in C57 BL/6J and DBA/2J mice. (1981) (17)
Ca2+/phospholipid-binding and syntaxin-binding of native synaptotagmin I. (1997) (16)
Long‐term reduction of brain‐derived neurotrophic factor levels and signaling impairment following prenatal treatment with the cannabinoid receptor 1 receptor agonist (R)‐(+)‐[2,3‐dihydro‐5‐methyl‐3‐(4‐morpholinyl‐methyl) pyrrolo[1,2,3‐de]‐1,4‐benzoxazin‐6‐yl]‐1‐ naphthalenylmethanone (2007) (16)
Cocaine-induced glutamate receptor trafficking is abrogated by extinction training in the rat hippocampus. (2014) (16)
Modifications in brain cAMP- and calcium/calmodulin-dependent protein kinases induced by treatment with S-adenosylmethionine (1998) (16)
The antiviral and immunomodulatory activities of propolis: An update and future perspectives for respiratory diseases (2021) (16)
Reduced activation of intracellular signaling pathways in rat prefrontal cortex after chronic phencyclidine administration. (2008) (16)
Effect of single or repeated estrogen administration on tuberoinfundibular GABA neurons and anterior pituitary GABA receptors: Biochemical and functional studies (1985) (16)
Olanzapine, but not haloperidol, enhances PSA-NCAM immunoreactivity in rat prefrontal cortex. (2008) (16)
Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: dissociation from effects on prolactin secretion. (1987) (16)
Behavioral and biochemical correlates after haloperidol and clozapine long-term treatment. (1980) (16)
Glycosaminoglycans in human cerebral tumors. Part II. Histochemical findings and correlations. (1982) (15)
Cyclic nucleotides in experimental and human brain tumors (2004) (15)
INfluence of SCH 23390, a DA1-receptor antagonist, on the behavioural responsiveness to small and large doses of apomorphine in rats (1986) (15)
Aminoacid recovery via microdialysis and photoinduced focal cerebral ischemia in brain cortex of rats (1995) (15)
Upregulation of neurotrophins by S 47445, a novel positive allosteric modulator of AMPA receptors in aged rats (2017) (15)
Time-course changes in rat cerebral cortex subcellular distribution of the cyclic-AMP binding after treatment with selective serotonin reuptake inhibitors. (1998) (14)
The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia (2001) (14)
Chronic Restraint Stress Inhibits the Response to a Second Hit in Adult Male Rats: A Role for BDNF Signaling (2020) (14)
Decreased hippocampal BDNF expression after acute systemic injection of quinpirole (2001) (13)
Genome-wide analysis of LPS-induced inflammatory response in the rat ventral hippocampus: Modulatory activity of the antidepressant agomelatine (2018) (13)
Evidence for the existence of cAMP-dependent protein kinase phosphorylation system associated with specific phosphoproteins in stable microtubules from rat cerebral cortex (1993) (13)
Cerebellar cyclic GMP and behavioral effects after acute and repeated administration of benzodiazepines in mice. (1982) (13)
Experimental brain tumors by transplacental ENU (2004) (13)
Acute stress rapidly increases the readily releasable pool of glutamate vesicles in prefrontal and frontal cortex through non-genomic action of corticosterone (2014) (13)
Enduring behavioural and biochemical effects in the adult rat after prolonged postnatal administration of haloperidol (2004) (13)
Biochemical and molecular changes in rat cerebral cortex after chronic antidepressant treatment: 'in vitro' and 'in vivo' studies. (1990) (13)
Haloperidol and clozapine: specificity of action on GABA in the nigrostriatal system (1977) (13)
Effect of reboxetine treatment on brain cAMP- and calcium/calmodulin-dependent protein kinases (2001) (12)
Glycosaminoglycans in human cerebral tumors (2004) (12)
Synaptoproteomic Analysis of a Rat Gene-Environment Model of Depression Reveals Involvement of Energy Metabolism and Cellular Remodeling Pathways (2015) (12)
Neurochemical studies on GABAergic and aminergic systems in the rat brain following acute and chronic piracetam administration. (1985) (12)
A single exposure to cocaine during development elicits regionally-selective changes in basal basic Fibroblast Growth Factor (FGF-2) gene expression and alters the trophic response to a second injection (2015) (12)
A single cocaine exposure disrupts actin dynamics in the cortico-accumbal pathway of adolescent rats: modulation by a second cocaine injection (2017) (12)
Region-specific effects of developmental exposure to cocaine on fibroblast growth factor-2 expression in the rat brain (2016) (12)
Changes in nitric oxide metabolite levels in stimulated substantia nigra neurons (1997) (12)
Effects of withdrawal from repeated amphetamine exposure in peri-puberty on neuroplasticity-related genes in mice (2013) (12)
Stress and cocaine interact to modulate Arc/Arg3.1 expression in rat brain (2011) (12)
Ontogenetic studies on mu, delta and kappa opioid receptors in rat brain. (1986) (11)
Glutamate receptor-induced cyclic GMP formation in primary cultures of mesencephalic neurons. (1993) (11)
Dynamic modulation of basic Fibroblast Growth Factor (FGF-2) expression in the rat brain following repeated exposure to cocaine during adolescence (2013) (11)
From Healthy Aging to Frailty: In Search of the Underlying Mechanisms (2019) (11)
Long-Term Abstinence from Developmental Cocaine Exposure Alters Arc/Arg3.1 Modulation in the Rat Medial Prefrontal Cortex (2014) (11)
Cognitive Effects of Second-Generation Antipsychotics (2009) (11)
Biochemical changes in rat brain after acute and chronic administration of fluvoxamine, a selective 5-HT uptake blocker: comparison with desmethylimipramine (1986) (11)
Long-term treatment with s-adenosylmethionine induces changes in presynaptic cam kinase II and synapsin I (2001) (10)
Dopamine and acetylcholine interactions in brain structures of mouse strains with different sensitivities to morphine. (1977) (10)
Long-term soluble Aβ1–40 activates CaM kinase II in organotypic hippocampal cultures (2007) (10)
Serotonergic modulation of cortical rat noradrenergic system in the mechanism of action of antidepressant drugs. (1985) (10)
Compartmentation of Striatal Dopamine: Problems in Assessing the Dynamics of Functional and Storage Pools of Transmitters (1975) (10)
cAMP-dependent binding proteins and endogenous phosphorylation after antidepressant treatment (1991) (10)
Treatment of Age-Related Cognitive Dysfunction: Pharmacological and Clinical Evaluationthe Patronage of the Commission of the (1992) (10)
ELAV–GAP43 pathway activation following combined exposure to cocaine and stress (2011) (9)
Changes in signaling pathways regulating neuroplasticity induced by neurokinin 1 receptor knockout (2005) (9)
Biochemical and behavioral changes in rats after prolonged treatment with desipramine: interaction with p-chlorophenylalanine (1985) (9)
Neurochemical aspects of GABA and glutamate in the hypothalamo-pituitary system. (1981) (9)
Studies on the up regulation of alpha-adrenoceptors on rat hippocampal perikarya by chemical lesion of the median raphe nucleus. (1985) (9)
The long-term impact of early adversities on psychiatric disorders: focus on neuronal plasticity. (2015) (9)
Interaction of putative endogenous tryptolines with the hypothalamic serotonergic system and prolactin secretion in adult male rats. (1986) (9)
Expert opinion on Real World Evidence RWE in drug development and usage (2020) (9)
Effect of THIP and SL 76002, two clinically experimented GABA-mimetic compounds, on anterior pituitary GABA receptors and prolactin secretion in the rat. (1987) (9)
Lack of Sterol Regulatory Element Binding Factor-1 c Imposes Glial Fatty Acid Utilization Leading to Peripheral Neuropathy (2015) (9)
p-HYDROXYNOREPHEDRINE: ITS SELECTIVE DISTRIBUTION IN DIFFERENT RAT BRAIN AREAS (1974) (9)
Behavioural changes in rats after prenatal administration of typical and atypical antidepressants. (1984) (8)
Comparative evaluation of the behavioural consequences of prenatal and early postnatal exposure to haloperidol in rats. (1985) (8)
Endocrine Modulation of γ-Aminobutyric Acidergic Innervation in the Rat Fallopian Tube* (1986) (8)
Interaction of 3,8-diazabicyclo (3.2.1) octanes with mu and delta opioid receptors. (1988) (8)
Functional impairment in patients with major depression in clinical remission: results from the VIVAL-D-Rem, a nationwide, naturalistic, cross-sectional survey (2015) (8)
Ultrasonic vocalization in rodents: biological aspects and effects of benzodiazepines in some experimental situations. (1986) (8)
The influence of early postnatal treatment with haloperidol on the effects induced by small and large doses of apomorphine on locomotion of adult rats (1983) (8)
Dual gamma-aminobutyric acid control of prolactin secretion in the rat. (1979) (8)
The anterior amygdala dopamine sensitive adenylate cyclase: point of action of antipsychotic drugs. (1976) (8)
Prenatal exposure to methylazoxymethanol (MAM) acetate: effects on ultrasonic vocalization and locomotor activity in rat offspring. (1987) (8)
Dopamine reuptake inhibitors and dopamine releasers: differential effect on plasma prolactin in the rat. (1982) (8)
Effect of idebenone on in vivo serotonin release and serotonergic receptors in young and aged rats (1996) (7)
The hypothalamo-pituitary GABAergic regulation of prolactin release in the rat. (1986) (7)
Expression and phosphorylation of δ-CaM kinase II in cultured Alzheimer fibroblasts (2004) (7)
[Neuromediator changes during cerebral aging. The effect of Ginkgo biloba extract]. (1986) (7)
Effects of morphine and chlordiazepoxide on locomotor activity in two inbred strains of mice. (1981) (7)
Behavioural and biochemical effects in the adult rat after prolonged postnatal administration of clozapine (2004) (7)
GABAergic mechanisms in the control of PRL and GH release. (1981) (7)
The protein kinase A in platelets from patients with panic disorder (2002) (7)
Repeated cocaine exposure during adolescence impairs recognition memory in early adulthood: A role for BDNF signaling in the perirhinal cortex (2020) (7)
Evidences for a direct action in striatum of dopaminergic receptor antagonists mediating DOPAC formation. (1978) (6)
Possible involvement of ovarian mechanisms other than estrogen-progesterone secretion in the regulation of glutamic acid decarboxylase activity of the rat fallopian tubes. (1987) (6)
K-opioid receptor changes in experimental models of cerebral ischaemia and atherosclerosis in the rabbit. (1992) (6)
Time-dependent activation of MAPK/Erk1/2 and Akt/GSK3 cascades: modulation by agomelatine (2014) (6)
Long-Term Exposure to the Atypical Antipsychotic Olanzapine Differently UpRegulates Extracellular Signal-Regulated Kinases 1 and 2 Phosphorylation in Subcellular Compartments of Rat Prefrontal Cortex (2006) (6)
Presynaptic and transynaptic mechanisms involved in the subsensitivity of rat cortical noradrenergic system after long-term antidepressant treatment. (2009) (6)
Calcium‐dependent modulation of FGF‐2 expression in cultured cerebellar granule neurons (2000) (6)
Neurotransmitter systems and receptor plasticity in brain aging. (1989) (6)
The GABAergic extrinsic innervation of the rat fallopian tubes: biochemical evidence and endocrine modulation. (1986) (6)
Effects of morphine and chlordiazepoxide on avoidance behaviour in two inbred strains of mice (1981) (5)
The GABAergic system in the rat oviduct: presence, endocrine regulation and possible localization. (1989) (5)
Expression and phosphorylation of delta-CaM kinase II in cultured Alzheimer fibroblasts. (2004) (5)
Time in the brain : rythms of intercellular and intracellular processes (2010) (5)
Comparative in vitro and in vivo studies between morphine and methionine-enkephalin: genotype dependent response in two different strains of mice. (1978) (5)
Anterior pituitary GABA receptors in relation to prolactin secretion. (1983) (5)
Effects of GABA analogues and their interactions with morphine on locomotor activity in two inbred strains of mice. (1982) (4)
Receptor Interactions in Antidepressant Neurochemical Mechanisms: Modulation by Membrane Components (1987) (4)
Phytochemical analysis and potential natural compounds against SARS-CoV-2/COVID-19 in essential oils derived from medicinal plants originating from Lebanon. An information note (2021) (4)
Use of mass fragmentography to detect subcellular localization of drug metabolites acting as false transmitters. (1973) (4)
[Ca2+] Modulates the ratio between cycloxygenase and lipoxygenase metabolism of arachidonic acid in homogenates of hippocampal astroglial cultures (1995) (4)
Chronic Treatment with a Phytosomal Preparation Containing Centella asiatica L. and Curcuma longa L. Affects Local Protein Synthesis by Modulating the BDNF-mTOR-S6 Pathway (2020) (4)
Steady-state concentrations of choline and acetylcholine in rat brain parts during a constant rate infusion of deuterated choline (2004) (4)
Modification of presynaptic CaM kinase II affinity for ATP in hippocampus after long term blockade of serotonin reuptake. (2000) (4)
P.2.d.006 The novel antidepressant agomelatine reduces release of glutamate and related presynaptic mechanisms in rat hippocampus (2007) (4)
Just a Reflection: Does Drug Repurposing Perpetuate Sex-Gender Bias in the Safety Profile? (2021) (4)
Relevance of GABA in the nigrostriatal system. (1979) (4)
P.2.d.023 Synergic mechanisms in the modulation of BDNF and Arc following agomelatine administration (2009) (4)
Protein phosphorylation in rat cerebral cortex after desipramine treatment (1987) (3)
A mass fragmentographic study of amphetamine and metabolites in rat brain (1974) (3)
Monophenolic 2-amino-1-indanone and 2-amino-1-tetralone derivatives: synthesis and assessment of dopaminergic activity (1987) (3)
Measurement of acetylcholine turnover rate in discrete areas of rat brain. (1974) (3)
Effects of repeated tiapride administration on anterior pituitary dopamine receptors and prolactin release in the rat. (1987) (3)
On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines. (2018) (3)
Behavioural and biochemical effects in C57BL/6J mice after a prolonged treatment with the δ‐opiate antagonist ICI 154129 (1984) (3)
Abnormalities in a / b-CaMKII and related mechanisms suggest synaptic dysfunction in hippocampus of LPA 1 receptor knockout mice (2011) (3)
No occurrence of the glutamate transporter EAAT2 A206G polymorphism in schizophrenic subjects (2002) (3)
Genotype dependent response of morphine and methionine-enkephalin on the electrically induced contractions of the mouse vas deferens (1978) (3)
Targeting the Action of Antidepressant Drugs on Second-Messenger Systems (1996) (3)
Cerebral tumours induced by ENU; changes of adenylate cyclase activity in the tumour latency time (2005) (3)
Ischemic cerebral pathologies and K opioid receptors in rabbits. (1991) (3)
cortex by repeated administration of antipsychotic drugs. (2008) (3)
Cariprazine in the management of negative symptoms of schizophrenia: state of the art and future perspectives (2020) (3)
Short and long term induction of basic fibroblast growth factor gene expresion in rat CNS following kainic acid injection. (1994) (2)
Proceedings: Dopaminergic regulation of acetylcholine turnover rate in rat striatum. (1974) (2)
Effects of atypical antipsychotics on the inflammatory response system In schizophrenic patients resistant to treatment with haloperidol (1999) (2)
Lack of serotonergic modulation on 3H-imipramine binding sites in basal conditions and during prolonged treatment with desmethylimipramine. (1986) (2)
The novel antidepressant agomelatine reduces the release of glutamate induced by acute footshock stress in synaptosomes of prefrontal/frontal cortex (2008) (2)
Variations in Neuromediators in Cerebral Aging (1988) (2)
P.1.11 Selective effects of antidepressants on CREB phosphorylation and related kinase cascade (2004) (2)
Effects of quazepam and flurazepam on GABA-ergic transmission in mouse cerebellum: relationship between biochemical and behavioral activity. (1981) (2)
Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release. (1978) (2)
S.08.01 Early and time dependent effects of antidepressant treatments on rat hippocampal miRNome (2015) (2)
INTEGRATIVE MECHANISMS IN RECEPTOR DOWN REGULATION AFTER LONG-TERM ANTIDEPRESSANT TREATMENTS (1984) (2)
BIOCHEMICAL AND MOLECULAR STUDIES AFTER LONG TERM ADMINISTRATION OF 5HT REUPTAKE INHIBITORS: COMPARISON WITH OTHER ANTIDEPRESSANTS. (1992) (2)
Cyclic nucleotides in brain tumors (1979) (2)
In vivo effects of typical and atypical antidepressants on brain noradrenergic system: behavioural correlations. (1982) (2)
Proceedings of the 14th Collegium Internationale Neuro‐Psychopharmacologicum Congress (1984) (2)
Hippocampal hypoglycaemia-activated K+ channels: single-channel analysis of glucose and voltage dependence (1994) (2)
Endocrine modulation of gamma-aminobutyric acidergic innervation in the rat fallopian tube. (1986) (2)
Synaptoproteomics of Existing and new Animal Models of Depression (2008) (2)
PRICING FOR MULTI INDICATION MEDICINES: A DISCUSSION WITH ITALIAN EXPERTS (2022) (2)
Molecular neuroplasticity in mood disorders and drug action : lessons front a gene X environment model (2008) (2)
S.04.08 Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants (2012) (2)
Dopaminergic activity and stereochemical considerations for rigid angular tricyclic congeners of dopamine: benzoquinoxalines and naphthothiazines. (1990) (1)
P.4.c.005 Stress and corticosterone increase the readily releasable pool of vesicles in rat synaptosomes of prefrontal/frontal cortex (2013) (1)
Pharmacological bases of psychoneuroendocrinology: preclinical assessment of clinical facts (1980) (1)
A mass fragmentographic study of amphetamine and metabolites in rat brain. (1974) (1)
Acceleration of antidepressant-induced down regulation of ß receptors by changes in chemicophysical membrane properties after phospholipid treatment. (1984) (1)
P.2.b.003 Modulation of Arc and BDNF following acute and chronic administration of agomelatine in rats (2007) (1)
A new pharmacological step: The melatonergic approach (2007) (1)
Biological psychiatry : proceedings of the 5th World Congress of Biological Psychiatry, Florence, 9-14 June 1991 (1991) (1)
cAMP signalling system in the pharmacotherapy and pathophysiology of bipolar disorder (2000) (1)
PHARMACOLOGICAL IMPLICATIONS OF DOPAMINERGIC, CHOLINERGIC AND GABAERGIC NEURONS IN THE ACTION OF ANTIPSYCHOTICS AND NARCOTIC ANALGETICS (1978) (1)
Receptor modulation and cAMP dependent phosphorylation system after repeated antidepressant administration (1990) (1)
Modulation of the inflammatory response after the antidepressant agomelatine in rats (2012) (1)
Practical issues in clinical research of schizophrenia. (1997) (1)
Bioavailability of curcumin in the rat frontal lobe and hippocampus after repeated administration of MERIVA® (2016) (1)
REM-SLEEP PARAMETERS AND PSYCHIATRIC-DIAGNOSIS (1991) (1)
S.12.02 Ketamine restores changes in glutamate release, dendrite morphology and BDNF trafficking in the hippocampus of rats vulnerable to chronic mild stress (2017) (1)
P.1.22 Synaptoproteomic analysis of a rat model of depression with gene-environment interaction (2008) (1)
DEVELOPMENTAL RELATED CHANGES OF NEUROTROPHIC FACTOR EXPRESSION IN ANIMAL MODELS OF SCHIZOPHRENIA (2000) (1)
Time-dependent activation of MAPK/Erk1/2 and Akt/GSK3 cascades: modulation by agomelatine (2014) (1)
gamma-Aminobutyric acid (GABA) and dopamine (DA) interactions in the hypothalamo-pituitary system; physiological and functional role in prolactin secretion. (1982) (1)
Erratum: Acute Stress Responsiveness of the Neurotrophin BDNF in the Rat Hippocampus is Modulated by Chronic Treatment with (Neuropsychopharmacology (2008) 34 (1-10) DOI:10.1038/npp.2008.208) (2009) (1)
P.1.a.015 Epigenetic analysis reveals selective impairment of bdnf-6 expression and dendritic translocation in BDNF Val66Met transgenic mice (2012) (1)
cAMP-binding proteins after paroxetine and fluvoxamine treatment (1995) (1)
Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes (2013) (1)
P.2.b.012 Transcriptional changes of BDNF and clock genes in the rat prefrontal cortex following acute agomelatine administration (2010) (1)
Synthesis, binding affinities for alpha-adrenoceptor and eudismic analysis of chiral benzodioxane derivatives and their chiral opened analogues. (1988) (1)
72-2 cAMP dependent phosphorylation system in the pharmacotherapy and pathophyslology of affective disorders (1997) (1)
NEUROCHEMICAL AND BEHAVIOURAL CHANGES AFTER PROLONGED POSTNATAL EXPOSURE TO HALOPERIDOL (1984) (1)
cAMP-dependent phosphorylation system, a biochemical target in the action of antidepressant drugs (1992) (1)
S.04.01 Functional proteomic analysis of an animal model of depression combining genetic vulnerability and environmental stress (2006) (1)
P.2.a.006 Agomelatine and fluoxetine induce different and time-dependent modulation of rat hippocampal miRNome (2014) (1)
Inhibitory effect of lithium on protein phosphorylation system associated to neuronal cytoskeleton (1992) (1)
Pharmacology of anxiolytic drugs (1997) (1)
Variations of neuromediators in cerebral ageing. Effects of Ginkgo biloba extract (1986) (1)
P.3.010 Time-dependent effects of antidepressant treatments on miRNome expression profile in hippocampus of rats (2013) (0)
DOPAMINE SENSITIVE ADENYLATE CYCLASE IN SUBSTANTIA NIGRA: POSSIBLE SITE OF ACTION OF PSYCHOTROPIC DRUGS (1979) (0)
Stress, neuroplasticity and vulnerability to psychiatric disorders (2004) (0)
507 Brain tumors and cyclic nucleotides (1983) (0)
In vivo inhibition of striatal acetycholine turnover by L-DOPA, apomophine and (plus)-amphetamine. (1975) (0)
P.1.006 Influence of chronic stress exposure on cognitive performance: a role for glucocorticoid receptors (2017) (0)
Modulation of neurotrophic mechanisms and glutamate signalling after chronic treatment with the novel antipsychotic lurasidone in rats (2010) (0)
Progress in psychoneuroendocrinology : proceedings of the XI congress of the International Society of Psychoneuroendocrinology held in Florence, Italy, 16-20 June, 1980 (1980) (0)
Delta opioid receptor activation in cortical neuronsin vitro (1995) (0)
Does ovarian secretion regulate the gaba-ergic tone in the rat fallopian tube? (1986) (0)
P.2.d.005 Stress-induced changes of neuroplastic proteins and modulation by chronic antidepressant treatment (2008) (0)
P.1.05 Chronic stress alters cocaine-induced modulation of BDNF expression and signaling in rat brain (2009) (0)
Poster #6 ANTIDEPRESSANT AND NEUROPLASTIC PROPERTIES OF CHRONIC LURASIDONE TREATMENT IN SEROTONIN TRANSPORTER KNOCKOUT RATS (2012) (0)
90-88 Protein phosphorylation in bipolar patients (1997) (0)
Effect of the antidepressant agomelatine on the inflammatory response induced by lipopolysaccharide: a genome-wide study in the rat ventral hippocampus (2015) (0)
P.2.d.012 Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine (2012) (0)
rapid re-entrainment of the circadian clock in the Jet Lag paradigm (1992) (0)
P.2.006 Ontogeny of cognitive impairment following prenatal infection (2012) (0)
P.2.d.017 The new antidepressant duloxetine increases BDNF mRNA and protein levels in rat frontal cortex (2006) (0)
PLATELET 5-HT UPTAKE AND RESPONSE TO LITHIUM PROPHYLAXIS IN UNIPOLAR DEPRESSIVE PSYCHOSIS. PRELIMINARY DATA (1984) (0)
cAMP binding proteins after chronic treatment with antidepressants. (1989) (0)
Abstracts Second Congress of the European Society for Clinical Neuropharmacology (1995) (0)
Long-term treatment with antidepressant agents affects Ca2+/calmodulin protein kinase II in hippocampal presynapses (1994) (0)
P.1.022 Epigenetic modifications in transgenic mouse with human polymorphism (Val66Met) of BDNF gene (2011) (0)
Glutamate Transporters: Molecular Mechanisms of Functional Alteration and Role in the Development of Excitotoxic Neuronal Injury (1996) (0)
Role of Neuropsychopharmacology in Pharmacy Practice and Education (2018) (0)
P.1.21 Time-dependent and sequential modulation of signaling, CREB activation and BDNF expression induced by antidepressants (2007) (0)
Metabotropic glutamate receptors inhibit NMDA receptor activity and prevent neurotoxicity in mesencephalic neuronsin vitro (1995) (0)
EPS volume 12 issue 2 Cover and Back matter (2003) (0)
S.08.03 Repeated cocaine exposure during adolescence alters stress-induced glutamate signaling in rat prefrontal cortex (2014) (0)
Involvement of the IL-6 Signaling Pathway in the Anti-Anhedonic Effect of the Antidepressant Agomelatine in the Chronic Mild Stress Model of Depression (2022) (0)
High resolution selected ion monitoring of 5-methoxy-tryptoline in rat pineal gland: Light-dark related studies (1988) (0)
Glutamate receptor-induced cyclic GMP and inositol phosphate formation in primary cultures of mesencephalic neurons (1992) (0)
P.4.022 Analysis of miRNome expression profiles in hippocampus of rats treated with antidepressants (2012) (0)
Biochemical markers of experimental and human brain tumors (1985) (0)
S-11-3 Protein phosphorylation system as a biochemical marker to study onset of antidepressant action (1995) (0)
Pharmacology of Anxiolytic Drugs (Who Expert Series on Neuroscience, Vol 3) (1997) (0)
90-11 Pharmacological action of S-adenosylmethlonine on neuronal pre- and postsynaptic signal transduction (1997) (0)
Noradrenaline and serotonin in depression: consensus and controversies. (1999) (0)
S-22-5 Enhanced extracellular glutamate and delayed neurotoxicity in cortical neuroglial cocultures exposed to the glutamate uptake inhibitor PDC (1995) (0)
P.1.25 Chronic antidepressant treatments induces specific changes in BDNF expression and subcellular localization (2007) (0)
Effect of the antidepressant agomelatine on the IL-6 pathway in rats exposed to chronic mild stress: role of suppressor of cytokine signaling 3 SOCS3 (2016) (0)
P.1.g.060 Genome-wide analysis of lipopolysaccharide (LPS)-induced inflammatory response in the rat ventral hippocampus: modulatory activity of the antidepressant agomelatine (2015) (0)
P.1.003 Inflammatory response in the brain of rats exposed to chronic mild stress (2013) (0)
Neurophysiological Alterations During Cerebral Ischemia in Rabbits (2005) (0)
Behavioural and neurochemical changes produced by developmental exposure to psychotropic drugs: The role of pharmacogenetics (1985) (0)
Variations in N euromediators in Cerebral Aging Effect of Ginkgo Biloba Extract (1988) (0)
P.1.28 Modulation of intracellular signaling patwhays by acute swim stress in rat hippocampus (2008) (0)
P.1.26 Transcriptional and translational changes of activity-regulated cytoskeletal associated protein following duloxetine treatment (2007) (0)
Leveling glutamate release: A presynaptic path toward antidepressant action (2005) (0)
Some biological correlates of acute antidepressant activity in affective illness (1991) (0)
TIME-DEPENDENT EFFECTS OF ANTIDEPRESSANTS ON HIPPOCAMPAL MIRNOME (2013) (0)
Lack of Serotonin Transporter Alters BDNF Expression in the Rat Brain During Early Postnatal Development (2013) (0)
Δ9–tetrahydrocannabinol modulates fgf-2 expression in the rat central nervous system (2005) (0)
Analysis of neuroadaptive changes following co-treatment of lurasidone and valproic acid in rats (2012) (0)
P.1.27 Functional and molecular correlates of synaptic plasticity in a gene–environment combination rat model of depression (2007) (0)
P.1.008 Stress rapidly reorganizes the glutamate synapse in the prefrontal cortex of cocaine-withdrawn adolescent rats (2014) (0)
Modulatory activity of chronic treatment with the antidepressant agomelatine on LPS-induced inflammatory response in the rat ventral hippocampus: a genome wide analysis (2015) (0)
S-26-2 Physiopathological role of glutamate receptors in mesencephalic neurons in vitro (1995) (0)
P.2.a.007 Early and time-dependent modulation of rat hippocampal miRNome during treatment with agomelatine (2013) (0)
P.1.001 Chronic mild stress modulates the transcription of BDNF isoforms with brain region specificity: influence of antidepressant treatment (2011) (0)
24-6 The presynaptic release machinery: A novel site in the mechanism of action of antidepressant drugs (1997) (0)
Lithium effects on basal and stimulated CREB phosphorylation in SH-SY5Y cells: a bimodal action on CaMKIV and Erk1/2 (2006) (0)
cAMP-binding proteins after SSRI administration: 4.8 (1995) (0)
A single cocaine exposure disrupts actin dynamics in the cortico-accumbal pathway of adolescent rats: modulation by a second cocaine injection (2017) (0)
Lipopolysaccharide does not affect sucrose intake in stress-resilient rats: potential contribution of microglia (2016) (0)
Modulation of glutamate uptake by oxygen free radicals and changes in the expression of NMDA receptor subunits: relevance to neurotoxicity (1994) (0)
Role of protein phosphorylation in bipolar disorder and in the action of lithium (1995) (0)
The activation of the immune/inflammatory system is associated with the stress-induced anhedonia in rats: effect of pharmacological intervention (2014) (0)
Neurochemical, behavioural and cardiovascular effects after perinatal administration of drug influencing dopaminergic and adrenergic system (1984) (0)
Short communication Acute and chronic changes in K q -induced depolarization alter NMDA and nNOS gene expression in cultured cerebellar granule cells (1996) (0)
K-opioid receptors in an experimental model of cerebral ischemia in rabbit (1988) (0)
Long-Term Abstinence from Developmental Cocaine Exposure Alters Arc/Arg3.1 Modulation in the Rat Medial Prefrontal Cortex (2014) (0)
P.1.059 The presynaptic release apparatus: A main site in the mechanism of action of psychotropic drugs (1996) (0)
Behavioural responsiveness to muscimol and apomorphine 2 months after prolonged treatment with estradiol in rats (2004) (0)
Modification of transducing and intracellular mechanisms in rat cerebral cortex after chronic treatment with antidepressant drugs (1990) (0)
Antidepressant treatment restores stress-induced anhedonia and the associated activation of the inflammatory system in the rat brain (2015) (0)
Differential regulation of FGF-2 gene expression by MK-801 (dizocilpine) (2000) (0)
O-21-2 Long-term changes induced by anti-depressant drugs in the presynaptic release machinery (1996) (0)
S.20.03 Isoform expression and intracellular trafficking of BDNF following stress and antidepressant drug treatment (2009) (0)
Chronobiological Studies of Serotonin Uptake Complex: Relevance to Antidepressant Action (1990) (0)
ERK 1/2 and CaMKII: two novel targets for antipsychotic therapy? (2006) (0)
P.3.d.002 Modulation of neurotrophic mechanisms after chronic treatment with the novel antipsychotic lurasidone in rats (2011) (0)
S-33-5 Lithium effects on protein phosphorylation in bipolar and healthy subjects (1996) (0)
Short Communication f3PP and Tau Interaction A Possible Link between Amyloid and Neurofibrillary Tangles in Alzheimer's Disease (2007) (0)
Cerebrovascular disease and k-opioid receptors in the rabbit. (1990) (0)
Stress responsiveness is altered in AMPA receptor subunit 1 (GluR−A) knockout mice (2010) (0)
Receptor mediated responses and intracellular mechanisms after antidepressant treatment (1988) (0)
Increase of bFGF mRNA levels in rat central nervous system following convulsive seizures (1992) (0)
S.08.02 Role of Arc/Arg3.1 in the actions of psychostimulant drugs (2009) (0)
14:15 ONTOGENY OF COGNITIVE IMPAIRMENT FOLLOWING PRENATAL INFECTION (2012) (0)
P.1.014 Ketamine modulates glutamate release, BDNF trafficking and dendrite morphology in rats vulnerable to chronic mild stress (2017) (0)
S.17.04 Regulation of glutamate receptor gene expression in response to antipsychotic drug treatment (1997) (0)
Developmental Exposure to Cocaine Dynamically Dysregulates Cortical Arc/Arg3.1 Modulation in Response to a Challenge (2016) (0)
1256 – THE EFFECT OF CLOZAPINE AND ACETYLCHOLINE TURNOVER RATE IN RAT STRIATUM (1977) (0)
P.2.016 Investigating stress resilience and susceptibility: impact of lipopolysaccharide on the rat brain (2017) (0)
Expression and functional role of mGluR3 in substantia nigra neurons (1996) (0)
MODULATION OF BDNF EXPRESSION AFTER CHRONIC TREATMENT WITH THE NOVEL ANTIPSYCHOTIC LURASIDONE IN RATS : BASAL CHANGES AND STRESS RESPONSIVENESS (2011) (0)
S.4.08 Temporal and anatomical characterization of stress-related changes on BDNF expression in the rat central nervous system (2004) (0)
METHYLPHENIDATE AND ATOMOXETINE AFFECT BDNF EXPRESSION IN THE BRAIN OF SPONTANEOUS HYPERTENSIVE RATS. (2009) (0)
Acute and chronic changes in K q-induced depolarization alter NMDA and nNOS gene expression in cultured cerebellar granule cells (1996) (0)
P.2.d.024 Modulation of the neurotrophin BDNF in serotonin transporter mutant rats (2009) (0)
P.1.02 Effects of stress and antidepressants on glutamate release and presynaptic molecular mechanisms (2008) (0)
O-21-7 Phosphorylation by Ca2+/Calmodulin-dependent protein kinase II. Effect on Ca2+/Phospholipid binding (1996) (0)
Mental Disorders in the Elderly: New Therapeutic Approaches: Rome, April 1997 (1998) (0)
Establishing patient safety monitoring in the benefit-risk paradigm for off-label and emergency use of medications for COVID-19: A pharmacovigilance perspective (2022) (0)
Protein phosphorylation as intracellular target in the action of MAO-A inhibitors and other antidepressants (1993) (0)
The Role of Learned Pharmacology Societies during the COVID 19 epidemic experience of the Italian Society of Pharmacology (2020) (0)
T he protein kinase A in platelets from patients with panic disorder (2015) (0)
P-11-24 Regulation of FGF-1 and FGF-2 gene expression in primary culture of rat astrocytes following beta adrenergic receptor activation (1995) (0)
Effect of novel mGluR antagonists on signal transduction in mesencephalic and striatal neurons in vitro (1996) (0)
The novel antidepressant agomelatine reduces depolarization-evoked release of glutamate and SNARE complex in rat hippocampus (2007) (0)
Pharmacodynamics and pharmacokinetics as a possible causality in resistant depression (1998) (0)
The Role of Neurochemistry in Behavioural Teratology and Toxicology (1988) (0)
[Markers of brain tumors]. (1984) (0)
Evaluation of neuroinflammation in an animal model of depression : effect of antidepressant treatment (2015) (0)
Modulation of presynaptic release machinery by typical and typical antidepressants (1998) (0)
SS01-01 - A New Way To Manage Depression Successfully: Restoring Circadian Rhythms (2010) (0)
Editorial Board (2000) (0)
P.4.e.004 Acute ketamine restores deficits in glutamate release and related molecular mechanisms induced by chronic mild stress in vulnerable rats (2016) (0)
Behavioral and Biochemical Effects in the Adult Rat After Prolonged Postnatal Administration of Cataleptogenic and Non-cataleptogenic Neuroleptics (1983) (0)
Longitudinal changes of plasma HVA and 5-HIAA levels in schizophrenic patients resistant to neuroleptics (1999) (0)
P-2-16 Changes in the subcellular distribution of cAMP receptors after chronic treatment with fluvoxamine and paroxetine (1995) (0)
Modulation of 5 hydroxytryptamine uptake and tritiated imipramine recognition sites during aging (1985) (0)
cAMP-and Ca2+/Calmodulin-Dependent Protein Phosphorylation in the Action of Antidepressant Drugs: Early Action of Venlafaxine (1997) (0)
Agomelatine Treatment Induces Early and Time- dependent Modulation of Rat Hippocampal MiRNome (2013) (0)
Chronic antidepressants block the increase in depolarization-evoked release of glutamate induced by acute stress (2008) (0)
MA Riva cytoskeleton-associated protein stress-dependent regulation of brain-derived neurotrophic factor and activity-regulated Depression-prone mice with reduced glucocorticoid receptor expression display an altered (2010) (0)
Faculty Opinions recommendation of PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor. (2019) (0)
Functional proteomic analysis of an animal model of depression combining genetic vulnerability and environmental stress (2006) (0)
Regulation of NMDA Receptor Expression in Response to Typical and Atypical Antipsychotics (1998) (0)
C.12.02 The interaction between the internal clock and antidepressant efficacy (2007) (0)
A single exposure to cocaine during development elicits regionally-selective changes in basal basic Fibroblast Growth Factor (FGF-2) gene expression and alters the trophic response to a second injection (2014) (0)
The presynaptic function as target for antidepressants (2000) (0)
Role of protein phosphorylation in bipolar illness: 12.5 (1995) (0)
P.1.g.029 Acute stress increases the readily releasable pool of glutamate vesicles in cortical areas (2014) (0)
P.1.060 Pharmacology of the presynaptic terminal: Modifications induced by antidepressant treatment in the phosphorylation of synaptotagmin and its functional properties (1996) (0)
P.1.025 Stress at the synapse: the synaptic action of acute behavioural stress and the protective effect of psychiatric drugs (2011) (0)
P.1.032 Study of the effect of acute stress on glutamate release in prefrontal/frontal cortex of antidepressant treated rats (2010) (0)
Inhibition of high-affinity glutamate uptake by arachidonic acid and oxygen free radicals: physiopathological significance (1993) (0)
S-29-5 Tumorigenesis and immune function in a transgenic mouse model of the endocrine changes seen in depression characterized by defective glucocorticoid feedback inhibition and HPA axis hyperactivity (1995) (0)
Neuroadaptive changes after chronic lurasidone treatment : implication for mood and stress-related disorders (2012) (0)
Region-specific effects of developmental exposure to cocaine on fibroblast growth factor-2 expression in the rat brain (2016) (0)
Light-Dark-Related Changes in the Serotonin Uptake Molecular Complex in Rat Brain: Involvement in Antidepressant Action (1989) (0)
T role of noradrenaline and selective noradrenaline reuptake inhibition in (2002) (0)
P.1.007 Time-course analysis of hormonal and neuroplastic changes in rats exposed to prenatal stress (2012) (0)
Adenylate cyclase activity and cyclic AMP content in human central nervous system tumors and in cerebrospinal fluid of patients bearing brain tumors (1986) (0)
Steady state and dynamics of putative neurotransmitters in tel-diencephalic nuclei: a study using multiple ion detection (1976) (0)
Modulation of presynaptic glutamate release: Implications for mood disorders and therapy (2006) (0)
Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid (2012) (0)
S.04.04 Temporal and anatomical characterization ofstress-related changes on BDNF expression in the rat central nervous system (2004) (0)
P.1.027 Modulation of the neurotrophin brain-derived neurotrophic factor in serotonin transporter mutant rats (2011) (0)
Significance of neurochemical parameters in the preclinical evaluation of neuroleptic drugs. (1979) (0)
P.1.07 Regulation of brain-derived neurotrophic factor expression by cocaine in rat brain and its modulation by stress (2008) (0)
158 Regulation of glutamate receptor gene expression in the rat brain following antipsychotic drug treatment (1997) (0)
Cyclic GMP inhibition of metabotropic glutamate receptor-induced phosphoinositide hydrolysis in mesencephalic neurons (1996) (0)
P.1.13 Hyperactivity and altered dopaminergicfunction in FGF-2 knockout mice (2005) (0)
P.3.d.019 Chronic olanzapine treatment affects intracellular signalling in selected subcellular compartments of rat prefrontal cortex (2006) (0)
Behavioural and neurochemical changes produced by lefetamine in two inbred strains of mice. (1989) (0)
Antidepressant and anti-inflammatory properties in the action of agomelatine (2013) (0)
Dynamic modulation of basic Fibroblast Growth Factor (FGF-2) expression in the rat brain following repeated exposure to cocaine during adolescence (2012) (0)
Genome-wide analysis of LPS-induced inflammatory response in the rat ventral hippocampus: modulatory activity of chronic treatment with the antidepressant agomelatine (2015) (0)
Synergy between melatonergic and 5-HT2C receptors in the action of agomelatine : molecular and cellular evidence (2012) (0)
Microtubules as possible target of camp dependent mechanisms coupled to neurotransmitter receptors (1990) (0)
S-44-3 Protein phosphorylation as intracellular target of antidepressants (1996) (0)
P-11-25 Regional regulation of FGF-1 and FGF-2 gene expression by pilocarpine in the rat central nervous system (1995) (0)
Altered inflammatory responsiveness in serotonin transporter mutant rats (2013) (0)
S-3-5 Long-term SSRI treatment increases Ca2+/calmodulin phosphorylation of presynaptic proteins: A new site in the mechanism of action of antidepressants (1995) (0)
Books Received (1998) (0)
P-11-20 Regulation of NMDA receptor subunit gene expression in rat cerebellar granule cells (1995) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Giorgio Racagni?

Giorgio Racagni is affiliated with the following schools:

Giorgio Racagni's Academic­Influence.com Rankings